Co-Authors
This is a "connection" page, showing publications co-authored by Ashish Sharma and Govindasamy Agoramoorthy.
Connection Strength
1.208
-
SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection. Ann Med Surg (Lond). 2021 Jun; 66:102428.
Score: 0.237
-
SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development. Expert Rev Clin Pharmacol. 2021 Feb; 14(2):225-238.
Score: 0.232
-
COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients. J Med Virol. 2020 11; 92(11):2260-2262.
Score: 0.222
-
Consider TLR5 for new therapeutic development against COVID-19. J Med Virol. 2020 11; 92(11):2314-2315.
Score: 0.221
-
Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants. mBio. 2021 08 31; 12(4):e0114021.
Score: 0.060
-
Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis. Vaccines (Basel). 2021 Jun 04; 9(6).
Score: 0.059
-
All Nations Must Prioritize the COVID-19 Vaccination Program for Elderly Adults Urgently. Aging Dis. 2021 Jun; 12(3):688-690.
Score: 0.059
-
The current second wave and COVID-19 vaccination status in India. Brain Behav Immun. 2021 Aug; 96:1-4.
Score: 0.059
-
SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics. Infect Genet Evol. 2021 04; 89:104729.
Score: 0.058